24                                                                                                                                                                                             Daily Nationffhursday              April 1, 2004
Local companies start producing Aids drugs
                                                                                                                                                                      Others believe multinational companies fear losing out their market
CONTINUED    FROM PAGE 23                                                                                                                                          share when the drugs are produced locally, and are therefore using
                                                                                                                                                                   their officials to influence decisions at the Ministry of Trade and
medicines for diseases such as malaria and tuberculosis-the only con-
                                                                                                                                                                   Industry.
dition being that such a disease is considered a national disaster.
                                                                                                                                                                     This is because if the generics are produced locally and sold at
   Kenya qualifies in all these fronts and consequently notified the
                                                                                                                                                                   lower prices, they are likely to push the multinational companies into
WTO of its intentions - to issue compulsory licensing and and/or                                                                                                   revising the prices of their branded ARVs downwards.
government order, licensing local companies to overlook certain pat-                                                                                                 Those who hold this position say their argument is based on the fact
ents and manufacture generic ARVs.                                                                                                                                 that the two first line drugs that are under patent, Lamivudine and
   Two of the three drugs - Lamivudine and Efavirenz- recom-                                                                                                       Efavirenz, are products of GlaxoSmithkline and Bristol Myers-Squibb
mended by the Ministry of Health as first line HIV treatment, are                                                                                                  respectively. Both companies have a strong presence locally.           ---oIIIIIIIiiiI
under patent.                                                                                                                                                         Indeed, speaking at the International Investment Confere~
   Only for the third, Stavudine, has the patent expired and it can be                                                                                             week, Trade and Industry minister Dr Mukhisa Kituyi revealed that a
produced by any company without a compulsory licence. But                                                                                                          local company wants a compulsory licence to manufacture one of the
because the drugs have to be taken as a triple therapy cocktail, it is                                                                                             products owned by GlaxoSmithkline.
instructive that companies also have a licence to produce the pat-                                                                                                    He admitted that the government was in a dilemma over the matter.
ented Lamivudine and Efavirenz.                                                                                                                                    The reason for this, as analysts see it; is that the affected multinational
   In the last few months, there have been press reports that Cosmos                                                                                               companies are operating in the country with local companies, and the
Ltd. has been denied a compulsory licence by the Ministry of Trade                                                                                                 government is finding it difficult to come up with a win-win situation.
and Industry to manufacture generic ARVs of some of these first line                                                                                                  When contacted over the issue, a source at GlaxoSmithkline said
drugs. Yet, the MoH has already given the company a clean bill of                                                                                                  the company was not worried about any local firm being granted a
health.                                                                                                                                                            licence to manufacture a generic version of its branded Lamivudine
   It is understood that a plea by Cosmos to the Ministry of Trade and                                                                                             drug.
Industry to be allowed to produce the drugs is yet to be considered.                                                                                                  Says the source: "We are highly subsidizing these drugs particularly
But in an interesting twist of events, a source at the Industrial Prop-                  Dr Mukhisa Kituyi                                                         for Africa. We don't make any profits here but only manage to break
erty Tribunal, the body that considers applications for such licence on                                                                                            even from sales in the developed countries."
behalf of the ministry, says no company has applied for compulsory                      under patent.                                                                 To the source, any company producing a generic of GSK branded
licensing.                                                                                 Likewise, it is instructive to note that most of the potent ARVs        products will be considered a partner. But he adds a rider: "However;
   "Some companies have been misleading the public through the                          drugs, especially the ones for emerging HIV-resistant strains, are still   matters of patent have to be looked into as something small has to
media that they have been denied compulsory licensing when they                         under patent, making compulsory licensing or Government Order the          accrue to us."
have not even applied for one," says the source.                                        only options for making them.                                                 What is happening in Kenya is said to have been rife in countries
   The source said Cosmos has only applied for a Government Order                          In essence, what this this means is that all products so far regis-     like India and Brazil where the governments overlooked the WTO
to produce generic ARVs, mainly because it had won a government                         tered and approved by the MoH for use in both public and private           patent rules and opposition from multinational pharmaceutical com-
tender.                                                                                 sector, but which are patented, cannot be manufactured for wider           panies to allow their local companies to manufacture generic ARVs
   In its application, Cosmos is said to have also expressed interest to                distribution unless the Ministry of Trade and Industry grants the          was strong.
produce for the private sector. This would have enabled the firm to                     compulsory licence or Government Order.                                       The issue has remained very sensitive, with some developed coun-
produce for the East African countries that would order for the drugs                      In fact, sources at MoH say even the government itself, through the     tries threatening to impose trade sanctions on the countries involved.
in line with the WTO's rules of parallel importation.                                   ministry, cannot tender for some drugs it has approved because such           Multinational pharmaceutical companies in the past have moved to
   The tribunal refused to grant that request, seeing another motive in                 a licence has not been issued so far to local companies.                   courts, in South Africa for instance, in an attempt to stop companies
the move. Says a source at the tribunal: "Their objective was only to                      Some stakeholders in the industry see an interplay of several fac-      in developing countries from reproducing their products without pay-
supply the government and not to produce the drugs for competitive                      tors as the reason behind the government's slow pace in issuing the        ing for it.
purposes. This set off alarm bells and we instead asked them to apply                   licences.                                                                     Their argument is that such moves will discourage Research and
for compulsory licensing."                                                                  There is talk that some foreign countries, which are home to major     Development (R&D) as most them are unable to recoup their invest-
   Universal Ltd and Lab and Allied will also have to seek this per-                    multinational pharmaceutical companies, are lobbying the govern-           ments.
mission if they want to produce the first line HIV drugs that are still                 ment not to grant such licence, at least not for now.                      - An A We-Feature
                                                                                               with                    C~/':
                                                                                                                           .
                                _                                                                          ,&L.
                                              A      ". 'it·
                                                          .··   . ··nt' ..... , '. · ,
                                                                                   ~ ~CAAIlNORE-·> . ....•..11··",' j
                                                                                                           ~St· .....•..•. 1                  m,.'J'
                                                                                                                  '.'..
                                                                                                           · .;,>;,·,ti";<                                                                               .
                                              .............           ·      ..... i.    ",",eM          > ( ..             0011
   On fri~ayt~e2n~of ApriI2~~4from 191tildawn
   Come and join the biggest Coast Night party                                                                                 • Sample excifin8!~~(Jstal dish
   Featuring the best Coastal music                                                                                              while danci         exotic,
                                                                                                                                    Nzele,&,                                        band
                                                                                                                                 from t_                                                                                                     ••••
  BRASSO BAND                                                                                                                                                                                                                                ~
                                                                                                                               • Free we                                                                                              I     \
  BANGO SOUNDS (Mzee Ngala Mwenyewe}                                                                                           • Mnazi in theibolf:s!                                                                                 ,')
  TALENTED TMRAB MELODIES                                                                                                                                                                                                             ~... ...•....
                                                                                                                                                                                                                                      t'.l
   UYOGA
   Dress code: Coast casual
   Entrance: Kshs. 300
Page 


-------------------Trial Version-----------------------

Convert PDF to Text Desktop Software.

Copyright Convertpdftotext.net 2014.

To remove these lines, please activate your software from http://www.convertpdftotext.net/buynow.htm

-------------------------------------------------------
